CSPC PHARMACEUTICAL GROUP LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.22 USD | -3.88% |
|
-6.80% | -12.74% |
| 06-12 | CSPC Pharmaceutical Buys Back Further Shares | MT |
| 06-11 | CSPC Pharmaceutical Repurchases 7 Million Shares | MT |
| Sales 2024 * | 37.88B 4.85B 6.64B | Sales 2025 * | 41B 5.25B 7.18B | Capitalization | 76.28B 9.78B 13.37B |
|---|---|---|---|---|---|
| Net income 2024 * | 7.15B 917M 1.25B | Net income 2025 * | 7.68B 984M 1.35B | EV / Sales 2024 * | 1.59 x |
| Net cash position 2024 * | 16.23B 2.08B 2.84B | Net cash position 2025 * | 20.9B 2.68B 3.66B | EV / Sales 2025 * | 1.35 x |
| P/E ratio 2024 * |
10.7
x | P/E ratio 2025 * |
9.99
x | Employees | 23,500 |
| Yield 2024 * |
3.3% | Yield 2025 * |
3.42% | Free-Float | 70.15% |
More Fundamentals
* Assessed data
More news
More recommendations
More press releases
More news
| 1 day | -3.88% | ||
| 1 week | -6.80% | ||
| Current month | -6.12% | ||
| 1 month | -4.99% | ||
| 6 months | -5.99% | ||
| Current year | -12.74% |
1 week
3.22
3.38
1 month
3.203.58
Current year
2.823.71
1 year
2.633.71
3 years
2.636.14
5 years
0.006.58
10 years
0.006.58
| Managers | Title | Age | Since |
|---|---|---|---|
Cui Long Zhang
CEO | Chief Executive Officer | 55 | 95-12-31 |
Dong Chen Cai
CHM | Chairman | 70 | 97-12-31 |
Hao Jiang
BRD | Director/Board Member | 41 | 20-07-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Dong Chen Cai
CHM | Chairman | 70 | 97-12-31 |
Huai Yu Wang
BRD | Director/Board Member | 61 | 09-12-31 |
Cheuk Kin Law
BRD | Director/Board Member | 61 | 21-03-07 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-06-20 | 3.22 | -3.88% | 3,205 |
| 24-06-18 | 3.35 | -0.74% | 21,936 |
| 24-06-17 | 3.375 | -1.17% | 3,733 |
| 24-06-14 | 3.415 | -1.16% | 2,139 |
| 24-06-13 | 3.455 | +0.55% | 2,677 |
Delayed Quote OTC Markets, June 20, 2024 at 03:42 pm
More quotes
CSPC Pharmaceutical Group Ltd. specializes in the development, manufacture and marketing of pharmaceutical products. Net sames by category of products break down as follows:
- drugs (78.7%): innovative drugs (62.5% of sales) and common generic drugs (37.5%);
- vitamin C (10.1%);
- antibiotics (6.2%);
- other (5%): including anhydrous and raw caffeine.
Net sales are distributed geographically as follows: China (82.8%), Asia (7.2%), Europe (4.6%), the Americas (4.4%) and others (1%).
Sector
Pharmaceuticals
Calendar
2024-08-20
- Q2 2024 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
6.44
HKD
Average target price
9.584
HKD
Spread / Average Target
+48.82%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +51.99% | 798B | |
| -5.72% | 356B | |
| +18.94% | 328B | |
| +11.07% | 304B | |
| +16.96% | 244B | |
| +2.25% | 227B | |
| +11.15% | 216B | |
| +7.59% | 166B | |
| -3.65% | 157B |
- Stock Market
- Equities
- 1093 Stock
- CSPCY Stock
